Fig. 1From: Metabolic profiling reveals metabolic features of consolidation therapy in pediatric acute lymphoblastic leukemiaSchema of the consolidation medication, plasma collection timing, and untargeted metabolomic profiling of pediatric acute lymphoblastic leukemia (ALL) patients. Plasma was collected from each patient before and after consolidation therapy (on day 1 and day 3, respectively). HDMTX, high-dose methotrexate; 6-MP, 6-mercaptopurine; CF, calcium folinateBack to article page